Antibiotic Resistance Market

About This Presentation

Title:

Antibiotic Resistance Market

Description:

The global antibiotic resistance market is anticipated to reach US$ 15.32 billion by 2028; growing at a CAGR of 6.3% during the forecast period, 2021 – 2028. Antibiotic resistance is a condition that occurs when the pathogens like bacteria & fungi develop the ability to minimize & kill the effects of the drugs designed to kill them i.e., the bacteria & fungi become immune to the drugs. This simply means that the drug has no effect on the bacteria & fungi and they continue to grow influentially. This condition is mostly developed by the excessive and uncontrolled use of antibiotics. – PowerPoint PPT presentation

Number of Views:66

Slides: 10

Provided by: priyasharma1

Category: Medicine, Science & Technology

more less

Transcript and Presenter's Notes

Title: Antibiotic Resistance Market

1
Antibiotic Resistance Market
sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
2
Antibiotic Resistance Market Global Scenario,
Market Size, Outlook, Trend, and Forecast, 2019
2028

The global antibiotic resistance market is
anticipated to reach US 15.32 billion by 2028
growing at a CAGR of 6.3 during the forecast
period, 2021 2028.
Antibiotic resistance is a condition that occurs
when the pathogens like bacteria fungi develop
the ability to minimize kill the effects of the
drugs designed to kill them i.e., the bacteria
fungi become immune to the drugs. This simply
means that the drug has no effect on the bacteria
fungi and they continue to grow influentially.
This condition is mostly developed by the
excessive and uncontrolled use of antibiotics.
Most of the antibiotics are sold at open drug
stores without being prescribed by the physician
and even some physicians prescribe antibiotics
without proper diagnosis. All these factors give
rise to the development of antibiotic resistance
which further drives the market of antibiotic
resistance products. Every year in the U.S., 2.8
million get infected with antibiotic-resistant
bacteria or fungi, and more than 35,000 people
die of antibiotic resistance. The risk of
antibiotic-resistant infections cannot be
completely avoided and people with chronic
diseases are more likely to develop the
condition. Antibiotic resistance is a threat to
mankind because if the antibiotics stop working,
our body loses the ability to treat the disease.
Currently, there is no proper treatment for
antibiotic resistance. Increasing antibiotic
infections and the emergence of various
drug-resistant pathogens are driving the market
growth of antibiotic resistance. However,
FDAapproved products like Clostridium difficile
infection (CDI) was launched in 2018 by the
ACX362E pharmaceuticals are very efficient in
the treatment of antibiotic resistance.

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
3
Market Dynamics

The increasing antibiotic infections, excessive
antibiotic usage, expanding bacterial
contamination, development of drug-resistant
pathogens, and growing clinical developments of
antibiotic resistance are the major factors that
are fueling the market growth of antibiotic
resistance. In addition, a rapid increment in
infectious chronic disease globally is also
pouring the market growth.
However, the high costs of the treatment
associated with the infections antibiotic
resistance and extended hospital stays hinder the
growth of the global antibiotic resistance
market.
The introduction of novel pipeline drugs, support
from the government, and extensive RD on
antibiotic resistance projects are providing
lucrative opportunities to the global market. In
addition, a large number of active market players
are investing in RD to provide better results in
antibiotic resistance. For example, Pfizer uses
drugs by Astra Zenecas, Zavicefta, and Zinforo,
which result in an expanded portfolio of
antibiotics.

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
4
Market Segmentation

The global antibiotic resistance market is
fragmented into Disease, Pathogen, Drug Class,
and region. The disease segment is further
sub-segmented into Blood Stream Infections (BSI),
Complicated Urinary Tract Infection (cUTI),
Clostridium difficile infections (CDI),
Complicated Intra-Abdominal Infections (cIAI),
Acute Bacterial Skin Skin Structure Infections
(ABSSSI), Community-Acquired Bacterial Pneumonia
(CABP), and Hospital-Acquired Bacterial
Pneumonia/Ventilator (HABP/VABP). Pathogen
segment is classified into Pseudomonas aeruginosa
(Carbapenem-Resistant), Staphylococcus Aureus
(Methicillin-Resistant), Acinetobacter baumannii
(Carbapenem-Resistant and ESBL-producing), E.
coli/K. pneumoniae (Carbapenem-Resistant),
Enterococcus faecium (Vancomycin-Resistant),
Haemophilus Influenzae (Ampicillin-Resistant),
and Clostridium difficile (Cephalosporin-Resistant
, Tetracycline-Resistant). Drug Class covers
Lipoglycopeptides, Oxazolidinones,
Cephalosporins, Tetracyclines, and Combination
therapies.

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
5
Geography Analysis

The global antibiotic resistance market is
segmented into North America, Europe,
Asia-Pacific, and RoW. North America is further
classified into U.S., Canada, and Mexico. Europe
is further segmented into Germany, the U.K.,
France, Italy, Spain, Russia, and the rest of
Europe. Asia-Pacific is segmented into China,
Japan, India, Australia, South Korea, and the
rest of APAC. The RoW includes South Central
America, the Middle East, and Africa. Currently,
North America dominates the global antibiotic
resistance market.
Prominent players of the global antibiotic
resistance market are Allergan, Pfizer, Johnson
Johnson, Merck, GlaxoSmithKline, Novartis,
Sanofi, and Melinta Therapeutics among others. In
this market, biotech companies are involved more
than pharmaceutical companies.

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
6
Market Segmentation and Scope of the Global
Antibiotic Resistance Market